Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab Gene Signatures in Adult Atopic Dermatitis
NCT04358224Phase 4Completed
- Start
- Sep 2020
- Primary completion
- Nov 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in atopic dermatitis (AD). Started Sep 2020; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04358224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04358224.